SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 993.48 |
Enterprise Value ($M) | 927.88 |
Book Value ($M) | 463.23 |
Book Value / Share | 3.16 |
Price / Book | 3.01 |
NCAV ($M) | 313.72 |
NCAV / Share | 3.01 |
Price / NCAV | 3.17 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.73 |
Return on Assets (ROA) | -0.46 |
Return on Equity (ROE) | -0.48 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 9.30 |
Current Ratio | 6.05 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 378.18 |
Assets | 527.70 |
Liabilities | 64.47 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -273.20 |
Net Income | -258.75 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -209.72 |
Cash from Investing | 131.71 |
Cash from Financing | 185.74 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Wellington Management Group Llp | 13.40 | 24.49 | |
13D/A | Rtw Investments, Lp | 17.60 | ||
13G/A | Vanguard Group Inc | 6.04 | 30.12 | |
13G/A | BlackRock, Inc. | 6.60 | 6.13 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
198,814 | 871,231 | 22.82 | |
180,338 | 883,253 | 20.42 | |
305,455 | 1,805,589 | 16.92 | |
188,206 | 864,322 | 21.77 | |
(click for more detail) |
Similar Companies | |
---|---|
QTTB – Q32 Bio Inc. | RANI – Rani Therapeutics Holdings, Inc. |
RAPT – RAPT Therapeutics, Inc. | RLAY – Relay Therapeutics, Inc. |
RNA – Avidity Biosciences, Inc. |